1933 Industries Inc C.TGIF

another bnn article --- Canadian TRENDS! thumbs up please!

[jfogarty12]

Analyst Call of the Week - RBC Capital Markets on Canadian valuations
 

RBC Capital Markets Analyst Douglas Miehm previewed the third-quarter for some of Canada's major cannabis players in a report to clients earlier this week, noting that valuations remain depressed given the uncertainty on U.S. legalization efforts and weaker-than-expected Q2 results. Miehm expects those valuations to bounce back somewhat amid improving sentiment as COVID-19 restrictions ease, more retail stores opening and various cost-cutting efforts. He sees the valuations for companies like Canopy Growth and Tilray (at 7.1x and 5.7x enterprise value-to-sales multiples respectively) reflecting their potential upside from entering U.S. and international markets, while Sundial’s valuation appears "overdone" due to speculative trading despite having $600 million in cash on its books.

Miehm also hiked his retail sales target for 2021 to $4.0 billion from $3.8 billion, while seeing 2022 sales climb to $4.8 billion. "We estimate new product launches, an increased numbers of stores, increased retail store traffic footprint and pricing declines to support the growth of the market, including migration of purchases from the illicit market to the regulated market," Miehm said. Sales of Cannabis 2.0 recreational products such as drinks and edibles should represent 37 per cent of the market by 2022, nearly double from 2020 sales, he estimates.